These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7357795)

  • 1. Intranasal and oral cocaine kinetics.
    Wilkinson P; Van Dyke C; Jatlow P; Barash P; Byck R
    Clin Pharmacol Ther; 1980 Mar; 27(3):386-94. PubMed ID: 7357795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of cocaine in humans after intravenous and intranasal administration.
    Javaid JI; Musa MN; Fischman M; Schuster CR; Davis JM
    Biopharm Drug Dispos; 1983; 4(1):9-18. PubMed ID: 6839006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine plasma concentration: relation to physiological and subjective effects in humans.
    Javaid JI; Fischman MW; Schuster CR; Dekirmenjian H; Davis JM
    Science; 1978 Oct; 202(4364):227-8. PubMed ID: 694530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cocaine contact anesthesia for endonasal surgery. Kinetics and clinical tolerance of a concentrated solution].
    Le Pelley E; Klossek JM; Bouquet S; Ferrier B; Fusciardi J
    Ann Fr Anesth Reanim; 1995; 14(6):472-7. PubMed ID: 8745970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.
    Coe MA; Jufer Phipps RA; Cone EJ; Walsh SL
    J Anal Toxicol; 2018 Jun; 42(5):285-292. PubMed ID: 29462364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cocaine: plasma concentrations and central effects.
    Van Dyke C; Jatlow P; Ungerer J; Barash PG; Byck R
    Science; 1978 Apr; 200(4338):211-3. PubMed ID: 24895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal cocaine: dose relationships of psychological effects and plasma levels.
    Van Dyke C; Ungerer J; Jatlow P; Barash P; Byck R
    Int J Psychiatry Med; 1982; 12(1):1-13. PubMed ID: 7095978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Haney M
    Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.
    Jufer RA; Walsh SL; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):435-44. PubMed ID: 9788518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.
    Jeffcoat AR; Perez-Reyes M; Hill JM; Sadler BM; Cook CE
    Drug Metab Dispos; 1989; 17(2):153-9. PubMed ID: 2565204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of cocaine.
    Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):459-78. PubMed ID: 8926741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.
    Cone EJ; Oyler J; Darwin WD
    J Anal Toxicol; 1997 Oct; 21(6):465-75. PubMed ID: 9323527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal cocaine in humans: effects of sex and menstrual cycle.
    Collins SL; Evans SM; Foltin RW; Haney M
    Pharmacol Biochem Behav; 2007 Jan; 86(1):117-24. PubMed ID: 17257663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits.
    Yagi N; Taniuchi Y; Hamada K; Sudo J; Sekikawa H
    Biol Pharm Bull; 2002 Dec; 25(12):1614-8. PubMed ID: 12499650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.
    Resnick RB; Kestenbaum RS; Schwartz LK
    Science; 1977 Feb; 195(4279):696-8. PubMed ID: 841307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of cocaine distribution, elimination, and chronotropic effects.
    Chow MJ; Ambre JJ; Ruo TI; Atkinson AJ; Bowsher DJ; Fischman MW
    Clin Pharmacol Ther; 1985 Sep; 38(3):318-24. PubMed ID: 4028628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.
    Chow HS; Chen Z; Matsuura GT
    J Pharm Sci; 1999 Aug; 88(8):754-8. PubMed ID: 10430537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.